Company / strategic investorRegistered location :New Brunswick, New Jersey 08933

Johnson & JohnsonDeclared Swiss shareholdings

Johnson & Johnson: 2 Swiss companies with a declared holding, including Actelion Ltd, Idorsia Ltd. Latest filing: 27.06.2026.

Disclosure tracking · company alerts with Pro

Estimated value (CHF): …
Swiss companies held: 2
Largest position: 93,42 %; Actelion Ltd
12-month trend: Net reducer; 0 rate rises · 1 rate falls
Latest filing: 27.06.2026; Active since 2014

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held

Actelion Ltd

93,42 %29.04.2017

Idorsia Ltd

8,67 %27.06.2026

How to read these figures?

Rates come from the 18 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure18 controls

Controls

Group entities linked to this shareholder in joint disclosures.

Cilag Holding AG8 · 27.06.2026
Johnson & Johnson Innovation-JJDC, Inc5 · 21.07.2020
Essex Woodlands Health Ventures Fund VIII-A, LP3 · 22.04.2016
Essex Woodlands Health Ventures Fund VIII-B, LP3 · 22.04.2016
Essex Woodlands Health Ventures Fund VIII, LP3 · 22.04.2016
Index Ventures IV Parallel Entrepreneur Fund Jersey , L.P2 · 13.12.2014
Endeavour II Guernsey L.P2 · 13.12.2014
BB Biotech Ventures II L.P2 · 13.12.2014
Johnson & Johnson Development Corporation2 · 13.12.2014
Yucca Jersey SLP2 · 13.12.2014
Index Venture IV Jersey , L.P2 · 13.12.2014
Yucca Jersey SLP, c/o Elian Employee Benefit Services Ltd1 · 22.04.2016
Endeavour II L.P1 · 22.04.2016
Endeavour Partners GP Limited1 · 22.04.2016
Index Ventures IV Jersey , L.P1 · 22.04.2016
Index Ventures IV Parallel Entrepreneur Jersey Limited1 · 22.04.2016
Janssen Holding GmbH1 · 29.04.2017
Actelion Ltd1 · 29.04.2017

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

visible history: 16

90 days · Downward crossings

visible history: 0

First disclosure: 11.11.2014Last disclosure: 27.06.2026

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings

Rights / derivatives

Sale positions

Declared Swiss portfolio

Sector allocation

Group structure

Controls

Disclosure behaviour

Nature of disclosed positions

Latest shareholding disclosures

Follow Johnson & Johnson’s disclosures

Management purchases in this portfolio

Common questions

Explore further

Recent insider purchases

Insider barometer